Evidence map›Paper›PMID 41940729›Full record

ArticlePsycho-oncology2026

Psychological Screening and Support for Patients Enrolled in Early-Phase Cancer Clinical Trials and the Possible Barriers: A Real-World Tertiary Center Implementation Study.

Matthew D Robinson, Ruiyang Yan, Amy Smith, Harriet Morley, Louise Carter, Donna Graham, Matt Krebs, Fiona Thistlethwaite, Natalie Cook

Abstract read
In one paragraph

Article in Psycho-oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Matthew D RobinsonExperimental Cancer Medicine Team, The Christie Hospital NHS Foundation Trust, Manchester, UK.ORCID https://orcid.org/0000-0002-6303-7121
Ruiyang YanExperimental Cancer Medicine Team, The Christie Hospital NHS Foundation Trust, Manchester, UK.
Amy SmithExperimental Cancer Medicine Team, The Christie Hospital NHS Foundation Trust, Manchester, UK.
Harriet MorleyExperimental Cancer Medicine Team, The Christie Hospital NHS Foundation Trust, Manchester, UK.
Louise CarterExperimental Cancer Medicine Team, The Christie Hospital NHS Foundation Trust, Manchester, UK.ORCID https://orcid.org/0000-0002-9854-2304
Donna GrahamExperimental Cancer Medicine Team, The Christie Hospital NHS Foundation Trust, Manchester, UK.
Matt KrebsExperimental Cancer Medicine Team, The Christie Hospital NHS Foundation Trust, Manchester, UK.
Fiona ThistlethwaiteExperimental Cancer Medicine Team, The Christie Hospital NHS Foundation Trust, Manchester, UK.ORCID https://orcid.org/0000-0002-4832-7008
Natalie CookExperimental Cancer Medicine Team, The Christie Hospital NHS Foundation Trust, Manchester, UK.ORCID https://orcid.org/0000-0003-2606-1082

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionOne in three patients with cancer suffers from clinically significant depression and/or anxiety. Early-phase cancer clinical trials (EPCCTs) frequently include patients with advanced disease with limited treatment options. However, screening for psychological symptoms is not routinely performed in this setting. Here, we describe a mixed-methods implementation study exploring the feasibility of improving access to psychological screening in EPCCTs and assessing how electronic patient-reported outcome measures (ePROMs) can be utilized to identify those requiring intervention.

methodsPerceived benefits and challenges associated with psychological screening in EPCCTs were explored from the clinician, psycho-oncology team, and patient and carer's perspectives, via clinician surveys and a patient and carer focus group. A standard workflow was created to enable routine psychological screening, alongside a stepped-care model for providing support. An ePROM, consisting of PHQ-2 and GAD-7 questionnaires, was distributed to patients enrolling on EPCCTs.

resultsOf the 17 clinicians who responded, 88% felt that routine psychological assessments were important, and 100% were willing to complete assessments with patients. Perceived barriers were identified relating to 4 main themes: resources, support services, training and staff misconceptions. Invitations to ePROMs were sent to 92 patients over 12 months and 59 (64.1%) have responded at baseline; of these, 13 (22.0%) patients have received intervention based on PHQ-2/GAD-7 score. Initial challenges associated with ePROM completion related to technological difficulties, missed notifications and form expiration.

conclusionOur findings suggest that routine psychological assessments in EPCCTs may help identify previously undiagnosed psychological burden in patients, and facilitate their access to appropriate, timely support. This implementation study indicates this approach can be feasibly delivered through the use of ePROMs.

Indexed as

AnxietyClinical Trials as TopicDepressionMass ScreeningNeoplasmsAdultAgedFeasibility StudiesFemaleFocus GroupsHumansMaleMiddle AgedPatient Reported Outcome MeasuresSocial SupportSurveys and Questionnaires

Identifiers

PMID41940729
PMCPMC13051752

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.